Cargando…
Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy
Relapse in patients with acute myeloid leukemia (AML) is common and is associated with a dismal prognosis. Treatment options are limited and the understanding of molecular response patterns is still challenging. We analyzed the clonal response patterns of 15 patients with relapsed/refractory AML tre...
Autores principales: | Klement, Piroska, Fiedler, Walter, Gabdoulline, Razif, Dallmann, Louisa-Kristin, Wienecke, Clara Philine, Schiller, Johannes, Kandziora, Christian, Teich, Katrin, Heida, Bennett, Büttner, Konstantin, Brandes, Maximilian, Funke, Carolin, Wichmann, Martin, Othman, Basem, Chromik, Joerg, Amberg, Stefanie, Kebenko, Maxim, Schlipfenbacher, Vera, Wilke, Anne Christine, Modemann, Franziska, Janning, Melanie, Serve, Hubert, Bokemeyer, Carsten, Theile, Susann, Deppermann, Ute, Kranich, Anne L., Ganser, Arnold, Thol, Felicitas, Heuser, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889470/ https://www.ncbi.nlm.nih.gov/pubmed/36576532 http://dx.doi.org/10.1007/s00277-022-05075-4 |
Ejemplares similares
-
MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AML
por: Teich, Katrin, et al.
Publicado: (2023) -
IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction—a retrospective propensity score analysis
por: Kattih, Badder, et al.
Publicado: (2020) -
Selinexor for multiple myeloma
Publicado: (2022) -
Newly diagnosed isolated myeloid sarcoma–paired NGS panel analysis of extramedullary tumor and bone marrow
por: Engel, Nils W., et al.
Publicado: (2020) -
Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia
por: Sharma, Amit, et al.
Publicado: (2020)